177 related articles for article (PubMed ID: 36140394)
1. Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane.
Swaih AM; Breda C; Sathyasaikumar KV; Allcock N; Collier MEW; Mason RP; Feasby A; Herrera F; Outeiro TF; Schwarcz R; Repici M; Giorgini F
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140394
[TBL] [Abstract][Full Text] [Related]
2. The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease.
Campesan S; Green EW; Breda C; Sathyasaikumar KV; Muchowski PJ; Schwarcz R; Kyriacou CP; Giorgini F
Curr Biol; 2011 Jun; 21(11):961-6. PubMed ID: 21636279
[TBL] [Abstract][Full Text] [Related]
3. Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease.
Thevandavakkam MA; Schwarcz R; Muchowski PJ; Giorgini F
CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):791-800. PubMed ID: 20942784
[TBL] [Abstract][Full Text] [Related]
4. A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics.
Maddison DC; Alfonso-Núñez M; Swaih AM; Breda C; Campesan S; Allcock N; Straatman-Iwanowska A; Kyriacou CP; Giorgini F
PLoS Genet; 2020 Nov; 16(11):e1009129. PubMed ID: 33170836
[TBL] [Abstract][Full Text] [Related]
5. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of kynurenine 3-monooxygenase inhibition.
Amaral M; Levy C; Heyes DJ; Lafite P; Outeiro TF; Giorgini F; Leys D; Scrutton NS
Nature; 2013 Apr; 496(7445):382-5. PubMed ID: 23575632
[TBL] [Abstract][Full Text] [Related]
7. Kynurenine-3-monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression.
Chen Y; Zhang J; Yang Y; Xiang K; Li H; Sun D; Chen L
J Cell Physiol; 2022 Dec; 237(12):4339-4355. PubMed ID: 36088660
[TBL] [Abstract][Full Text] [Related]
8. Bacterial expression of human kynurenine 3-monooxygenase: solubility, activity, purification.
Wilson K; Mole DJ; Binnie M; Homer NZ; Zheng X; Yard BA; Iredale JP; Auer M; Webster SP
Protein Expr Purif; 2014 Mar; 95(100):96-103. PubMed ID: 24316190
[TBL] [Abstract][Full Text] [Related]
9. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
Wang H; Lim PJ; Karbowski M; Monteiro MJ
Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
[TBL] [Abstract][Full Text] [Related]
10. Dual role of the carboxyl-terminal region of pig liver L-kynurenine 3-monooxygenase: mitochondrial-targeting signal and enzymatic activity.
Hirai K; Kuroyanagi H; Tatebayashi Y; Hayashi Y; Hirabayashi-Takahashi K; Saito K; Haga S; Uemura T; Izumi S
J Biochem; 2010 Dec; 148(6):639-50. PubMed ID: 20802227
[TBL] [Abstract][Full Text] [Related]
11. Drosophila eye color mutants as therapeutic tools for Huntington disease.
Green EW; Campesan S; Breda C; Sathyasaikumar KV; Muchowski PJ; Schwarcz R; Kyriacou CP; Giorgini F
Fly (Austin); 2012; 6(2):117-20. PubMed ID: 22634544
[TBL] [Abstract][Full Text] [Related]
12. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.
Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ
J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070
[TBL] [Abstract][Full Text] [Related]
13. Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma.
Sathyasaikumar KV; Pérez de la Cruz V; Pineda B; Vázquez Cervantes GI; Ramírez Ortega D; Donley DW; Severson PL; West BL; Giorgini F; Fox JH; Schwarcz R
Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204197
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors.
Smith JR; Jamie JF; Guillemin GJ
Drug Discov Today; 2016 Feb; 21(2):315-24. PubMed ID: 26589832
[TBL] [Abstract][Full Text] [Related]
15. Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's disease.
Bondulich MK; Fan Y; Song Y; Giorgini F; Bates GP
Sci Rep; 2021 Mar; 11(1):5484. PubMed ID: 33750843
[TBL] [Abstract][Full Text] [Related]
16. Assessing and Modulating Kynurenine Pathway Dynamics in Huntington's Disease: Focus on Kynurenine 3-Monooxygenase.
Sathyasaikumar KV; Breda C; Schwarcz R; Giorgini F
Methods Mol Biol; 2018; 1780():397-413. PubMed ID: 29856028
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback.
Wilson K; Auer M; Binnie M; Zheng X; Pham NT; Iredale JP; Webster SP; Mole DJ
Cell Death Dis; 2016 Apr; 7(4):e2197. PubMed ID: 27077813
[TBL] [Abstract][Full Text] [Related]
18. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
Akbergenova Y; Littleton JT
J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896
[TBL] [Abstract][Full Text] [Related]
20. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice.
Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K
Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
